Observed Signal · Nov 13, 2026 · regulatory · Source: SEC API · Impact: 4.5/5
KNOREX Faces Delisting as NYSE American Suspends Class A Ordinary Shares
On November 11, 2026, KNOREX Ltd. was notified by NYSE American LLC that the exchange immediately suspended trading in its Class A ordinary shares and commenced proceedings to delist the stock under Section 1003(f)(v) of the NYSE American Company Guide due to an abnormally low selling price. KNOREX intends to appeal the decision by requesting a hearing before the Listing Qualifications Panel prior to the November 18, 2026 deadline. During the appeal, shares will remain suspended from trading. To regain compliance and defend its listing, the company plans to pursue a reverse stock split, though no assurance can be given regarding a successful outcome.
Immediate trading suspension and delisting proceedings from a primary U.S. exchange pose an acute liquidity and capital market crisis for the public adtech firm.
MARKET SIGNALS
Track KNOREX Signals & Strategic Shifts
Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.
- Verified primary sources
- Automated briefings
- Instant watchlist setup
Key Takeaways & Evidence Grounding
- NYSE American suspended trading in KNOREX Class A ordinary shares on November 11, 2026, and initiated delisting proceedings under Section 1003(f)(v) due to low share price.
- KNOREX must submit its appeal request to the Listing Qualifications Panel by November 18, 2026, to challenge the delisting determination.
- Trading remains suspended during the appeal process, and KNOREX plans to seek a reverse stock split to regain compliance.
Connected Companies & Entities
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
6-K Financial Filing Analysis for KNOREX (2026-08-26)
On August 21, 2026, KNOREX Ltd. received a deficiency notice from NYSE Regulation regarding non-compliance with NYSE American continued listing standards under Sections 1003(a)(i) and 1003(a)(ii). The non-compliance stems from consecutive net losses over the last four fiscal years and a stockholders' deficit of $(6.5) million as of December 31, 2025, against minimum stockholders' equity requirements of $2.0 million to $4.0 million. The company plans to submit a compliance plan by September 20, 2026, seeking to regain compliance by February 21, 2028, during which its Class A ordinary shares will continue trading normally subject to NYSE acceptance and progress milestones.
6-K Financial Filing Analysis for KNOREX (2026-10-28)
Knorex Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on October 28, 2026, furnishing its unaudited condensed consolidated financial statements and operating and financial review for the six months ended June 30, 2026, and 2025. The filing serves as the company's semi-annual financial disclosure required for foreign private issuers, incorporating interim financial results in Exhibit 99.1 and accompanying management commentary in Exhibit 99.2.
Genius Group Announces 1-for-10 Share Consolidation Following NYSE American Trading Halt
Genius Group Limited announced that NYSE Regulation halted trading of its ordinary shares on November 10, 2026, due to an abnormally low trading price. To address listing compliance and facilitate the resumption of trading, the company is executing a 1-for-10 share consolidation (reverse stock split). The consolidation is scheduled to take effect at 12:01 a.m. Eastern Time on November 20, 2026, with trading expected to resume on a split-adjusted basis at market open under the ticker 'GNS'.
WATCHLIST & BRIEFINGS
Receive future signals for KNOREX & competitors in your briefing
Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.
- Regular primary-source checks
- Structured Watchlist briefings
- Preserves current context
Market Signal Monitoring
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
Monitor KNOREX
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
